Global Biosimulation Market Size & Outlook, 2025-2030
Global biosimulation market, 2018-2030 (US$M)
Related Markets
Global biosimulation market highlights
- The global biosimulation market generated a revenue of USD 3,910.0 million in 2024 and is expected to reach USD 10,005.0 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 17% by 2030.
- In terms of segment, software accounted for a revenue of USD 2,817.0 million in 2024.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Canada is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 3,910.0 million |
| Market revenue in 2030 | USD 10,005.0 million |
| Growth rate | 17% (CAGR from 2025 to 2030) |
| Largest segment | Software |
| Fastest growing segment | Services |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Services |
Other key industry trends
- In terms of revenue, the North America accounted for 49.9% of the global biosimulation market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Canada is the fastest growing regional market and is projected to reach USD 473.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biosimulation Market Scope
Biosimulation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Immunetrics | View profile | 11-50 | Pittsburgh, Pennsylvania, United States, North America | http://www.immunetrics.com |
| Yokogawa Electric Corp. | View profile | 10001+ | Tokyo, Tokyo, Japan, Asia | http://www.yokogawa.com |
| Instem | View profile | 51-100 | Conshohocken, Pennsylvania, United States, North America | http://www.instem.com |
| Genedata AG | View profile | 51-100 | Basel, Basel-Stadt, Switzerland, Europe | https://www.genedata.com/ |
| Rosa & Co | View profile | 11-50 | San Carlos, California, United States, North America | http://www.rosaandco.com |
| Physiomics | View profile | 11-50 | Oxford, Oxfordshire, United Kingdom, Europe | http://www.physiomics-plc.com/ |
| Chemical Computing Group | View profile | 11-50 | Montreal, Quebec, Canada, North America | https://www.chemcomp.com |
| Schrodinger Inc Ordinary Shares | View profile | 787 | 1540 Broadway, 24th Floor, New York, NY, United States, 10036 | https://www.schrodinger.com |
| Simulations Plus Inc | View profile | 197 | 42505 Tenth Street West, Lancaster, CA, United States, 93534-7059 | https://www.simulations-plus.com |
| Avantium NV | View profile | 249 | Zekeringstraat 29-31, Amsterdam, Netherlands, 1014 BV | https://www.avantium.com |
| Dassault Systemes SE | View profile | 23811 | 10, Rue Marcel Dassault, Velizy-Villacoublay, France, 78140 | https://www.3ds.com |
| Certara Inc Ordinary Shares | View profile | 1391 | 100 Overlook Center, Suite 101, Princeton, NJ, United States, 08540 | https://www.certara.com |
Global biosimulation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biosimulation market will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 72.05% in 2024. Horizon Databook has segmented the Global biosimulation market based on software, services covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Biosimulation Product Outlook (Revenue, USD Million, 2018-2030)
- Software
- Molecular Modeling & Simulation Software
- Clinical Trial Design Software
- PK/PD Modeling and Simulation Software
- Pbpk Modeling and Simulation Software
- Toxicity Prediction Software
- Other Software
- Services
- Contract Services
- Consulting
- Other
- Software
- Global Biosimulation Application Outlook (Revenue, USD Million, 2018-2030)
- Drug Discovery & Development
- Disease Modeling
- Other
- Global Biosimulation Therapeutic area Outlook (Revenue, USD Million, 2018-2030)
- Oncology
- Cardiovascular Disease
- Infectious Disease
- Neurological Disorders
- Others
- Global Biosimulation Deployment Model Outlook (Revenue, USD Million, 2018-2030)
- Cloud Based
- On premise
- Hybrid Model
- Global Biosimulation Pricing Model Outlook (Revenue, USD Million, 2018-2030)
- License based Model
- Subscription based Model
- Service based Model
- Pay Per Use Model
- Global Biosimulation End Use Outlook (Revenue, USD Million, 2018-2030)
- Life Sciences Companies
- Pharmaceutical Companies
- Biopharma Companies
- Medical Devices
- Academic Research Institutions
- Others
- Life Sciences Companies
Reasons to subscribe to Global biosimulation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global biosimulation market databook
-
Our clientele includes a mix of biosimulation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global biosimulation market , including forecasts for subscribers. This global databook contains high-level insights into Global biosimulation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global biosimulation market size, by regions, 2018-2030 (US$M)
Top 10 countries: Biosimulation market size, 2024 (US$M)
Global biosimulation market share, by product, 2024 & 2030 (%, US$M)
Biosimulation market: Opportunity assessment by country
Global biosimulation market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
